SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2025 ,inter alia, to consider and approve the Unaudited (Standalone ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Saturday, 9th August 2025 at the registered office in Hyderabad. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended 30th June 2025 (Q1 FY2026). The filing is made under SEBI Listing Regulations (Regulation 29). The company has also noted that the trading window for insiders has been closed since 1st July 2025 and will reopen on 12th August 2025, in line with insider trading norms.
This is a routine regulatory intimation with no financial numbers disclosed yet. Investors should watch for the actual Q1 results announcement on or after 9th August, which could move the stock depending on revenue and profit performance versus expectations.